Oncology is the leading therapy area for innovation – in terms of the level of clinical trial activity, number of companies investing in therapeutics, size of the pipeline of therapies in clinical development, novel active substances being launched, and the level of expenditure on these drugs[1].

On November 14th, JLABS @ Toronto will bring together experts for two engaging panel discussions covering advancements in oncology clinical trials and the current investment landscape of this therapeutic area. Panelists will explore how oncology clinical trials have advanced to create a more targeted experience for patients, and greater value for products in development. We will also discuss how the lessons learned can be applied to future innovation in clinical trials.  Following this discussion, VCs and investors from the US & Canada will speak to the challenges and opportunities of oncology investment in 2023, and what trends they see coming over the next few years.